pharma · Psoriasis Vulgaris · Moderate-to-severe plaque psoriasis and a body weight ≥120 kg.
LEO Pharma US
LEO Pharma A/S
LEO Pharma US clinical programs — 1 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Madison, USA HQ
1908 Founded
75 Employees
EMA registrant Type
Company details
- Status
- Public
- HQ
- Madison, USA
- Founded
- 1908
- Employees
- 75
- Programs
- 7
- Drugs
- 11
- Patents
- 0
LEO Pharma US projects
1 ClinicalTrials.gov programs sponsored by LEO Pharma US.
LEO Pharma US has 1 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
Frequently asked questions
How many clinical projects does LEO Pharma US have?
1 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.